HOME >> MEDICINE >> NEWS
Changing chemistry helps explain estrogen threat to the heart

A piece of the topical puzzle of how estrogen goes from protecting women from heart disease to apparently increasing their risk later in life may have been found.

Medical College of Georgia researchers have found changes in blood vessel chemistry that may explain the dramatic flip-flop in estrogen's function that occurs in older women, taking it from a dilator of vessels to a potentially dangerous constrictor, says Dr. Richard White, MCG pharmacologist.

Dr. White will present the findings at the American Heart Association's Second International Conference on Women, Heart Disease and Stroke in Orlando, Fla., Feb. 16-19.

He hopes the findings will ultimately make hormone replacement therapy safer, possibly by adding to the mix compounds that enable estrogen's protective role before menopause.

Hormone replacement therapy, touted for its ability to reduce the risk of heart attack and stroke in postmenopausal women, appears to increase the risk of those conditions, according to findings of the Women's Health Initiative, a 15-year study of more than 161,000 women by the National Institute of Health's National Heart, Lung and Blood Institute.

This bad news about estrogen and the heart puzzled Drs. White and Scott A. Barman, also an MCG pharmacologist, as much as it did many physicians who had long prescribed it.

They were studying estrogen's effects on blood vessels, focusing on its impact on the smooth muscle cells that allow blood vessels to contract, thereby regulating blood pressure and blood flow. These researchers found that estrogen targets nitric oxide synthase 1, one of three versions of the enzyme that makes the powerful vasodilator, nitric oxide.

"What we were finding is that estrogen seems to be what you might call a natural nitroglycerin; nitroglycerin also works by making nitric oxide," Dr. White says.

Then they tried to block estrogen's activity by blocking nitric oxide. "What surprised the
'"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
16-Feb-2005


Page: 1 2 3

Related medicine news :

1. Changing trends in herbal supplement use
2. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
3. Changing the timing of cancer vaccines
4. Changing prescribing behaviour through the mail
5. Changing partner increases risk of preterm birth
6. Changing Life, Challenging Cancer conference
7. Changing approaches to treating gum disease
8. Changing Drug Delivery For Rheumatoid Arthritis Patients Increases Effectiveness, Lowers Costs
9. NJIT chemistry professor edits text outlining best laboratory practices
10. Sealing corneal incisions with a drop of chemistry, BU researchers develop gel for cataract surgery
11. Herbal supplements testing topic of discussion at chemistry meeting March 30

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Changing chemistry helps explain estrogen threat the heart

(Date:5/26/2015)... Mr. Larry Westenberg is a Licensed ... Programming, or NLP. Mr. Westenberg is recently also ... or RRT®. While many people have learned small ... to specific areas, Mr. Westenberg has been studying the ... years. He works with people suffering the effects ...
(Date:5/26/2015)... Santa Rosa, CA (PRWEB) May 26, 2015 ... Management and Analytics solutions for more than 15 years, ... from the National Committee for Quality Assurance (NCQA) for ... today. , “We are proud of the work we ... years and are grateful for the acknowledgement from NCQA ...
(Date:5/26/2015)... OR (PRWEB) May 26, 2015 The ... fatal if not caught early. Melanoma is also easily ... advocate Sharon Kleyne, the melanoma rate is on the ... While the melanoma risk for indoor tanning salon patrons ... establishments. The most recent ban, in Pennsylvania, coincides with ...
(Date:5/26/2015)... PA (PRWEB) May 26, 2015 ... XML Editor with the Vasont® CCMS to make ... Vasont Systems, a top component content management system ... Integrator (VUI) extension supports oXygen XML Editor Version ... The Vasont Universal Integrator extension merges key editorial ...
(Date:5/26/2015)... May 26, 2015 The European imaging IT ... over 45% of healthcare providers plan to make purchases. ... industry report. Data collected from these participants show that speech ... takes a back seat. , “Many imaging IT vendors ... said peer60 CEO Jeremy Bikman. “This report details the European ...
Breaking Medicine News(10 mins):Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 2Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 3Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 2Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 3Health News:Vasont Systems Certifies the Integration between the Vasont® Component Content Management System and oXygen® XML Editor 17.0 2Health News:peer60 report: European Healthcare IT Imaging Purchases: 2015 2
(Date:5/26/2015)... May 26, 2015 Boehringer Ingelheim today ... (FDA) approved once-daily STIOLTO™ RESPIMAT ® (tiotropium ... approved as a long-term, once-daily maintenance treatment of ... disease (COPD), including chronic bronchitis and/or emphysema. STIOLTO ... acute deterioration of COPD. COPD, which ...
(Date:5/26/2015)... -- Organovo Holdings, Inc. (NYSE MKT: ONVO; "Organovo"), a three-dimensional ... announced today that the company will present at an ... be held in New York , ... Chairman and Chief Executive Officer, will deliver a company ... Details of the presentations are as follows: ...
(Date:5/26/2015)... 26, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering and developing innovative therapies primarily ... today announced that the Company,s President and CEO, ... at the Jefferies 2015 Global Healthcare Conference ... a.m. EDT. Dr. Cauwenbergh will present a ...
Breaking Medicine Technology:FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 2FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 3FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 4FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 5FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 6FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 7FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 8FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 9FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 10FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 11FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 12FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 13Organovo Holdings, Inc. To Present at Jeffries 2015 Healthcare Conference 2Organovo Holdings, Inc. To Present at Jeffries 2015 Healthcare Conference 3RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 2RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 3RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 4
Cached News: